Hugeraw Health Technology Co.,Ltd.
Products
Contact Us
  • Contact Person : Ms. mandy zhang
  • Company Name : Hugeraw Health Technology Co.,Ltd.
  • Tel : 86-523-51904695
  • Fax : --
  • Address : jiangsu,taizhou,Area A ,No. 1 pharmaceutical high tech Industrial Park,Yao Cheng Avenue,Taizhou ,China
  • Country/Region : China

Fluoxymesterone CAS No: 76-43-7

Fluoxymesterone CAS No: 76-43-7
Product Detailed
Related Categories:Pharmaceutical
Fluoxymesterone CAS No: 76-43-7 Molecular formula: C20H29FO3 Molecular weight: 336.44 Appearance: White or Almost White Crystalline Powder. Assay: 99%min Delivery time: 5-7days working days door to door Minimum order: 1g Supply ability: 100kg/month Quality standard: USP32 Detail: Fluoxymesterone (trade name Halotestin) is an anabolic steroid with strong androgenic properties that has been used in the treatment of male hypogonadism, delayed puberty in males, and in the treatment of breast neoplasms in women. It is approximately 5 times as potent as methyltestosterone. The antitumor activity of fluoxymesterone appears related to reduction or competitive inhibition of prolactin receptors or estrogen receptors or production. Fluoxymesterone is a synthetic androgen steroid hormone available by prescription. It may be given to men who have medical conditions that lower or inhibit the body’s natural production of testosterone or to women with certain forms of breast cancer. Health-care providers generally warn the drug can cause a variety of possible side effects and may not recommend its use in certain patients due to potentially serious side effects. The primary uses of fluoxymesterone are in men with lower levels of androgen hormones, which may be seen in conditions such as hypogonadism or delayed puberty. Androgen hormones are also often called male hormones, and are primarily responsible for male sexual development. Testosterone, which begins forming in males in the womb and promotes the development of a penis, testes and a scrotum, is the most known androgen hormone.


Copyright Notice @ 2008-2022 ECBAY Limited and/or its subsidiaries and licensors. All rights reserved.